Literature DB >> 11584571

New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.

P W Armstrong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11584571      PMCID： PMC81461     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  27 in total

1.  Bolus fibrinolysis: risk, benefit, and opportunities.

Authors:  P W Armstrong; C Granger; F Van de Werf
Journal:  Circulation       Date:  2001-02-27       Impact factor: 29.690

2.  Thrombolytic therapy in the elderly.

Authors:  H D White
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

3.  Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.

Authors:  A Schömig; A Kastrati; J Dirschinger; J Mehilli; U Schricke; J Pache; S Martinoff; F J Neumann; M Schwaiger
Journal:  N Engl J Med       Date:  2000-08-10       Impact factor: 91.245

4.  Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial.

Authors:  R V Luepker; J M Raczynski; S Osganian; R J Goldberg; J R Finnegan; J R Hedges; D C Goff; M S Eisenberg; J G Zapka; H A Feldman; D R Labarthe; P G McGovern; C E Cornell; M A Proschan; D G Simons-Morton
Journal:  JAMA       Date:  2000-07-05       Impact factor: 56.272

5.  Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group.

Authors: 
Journal:  Circulation       Date:  2000-06-20       Impact factor: 29.690

6.  Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis.

Authors:  S R Mehta; J W Eikelboom; S Yusuf
Journal:  Lancet       Date:  2000-08-05       Impact factor: 79.321

7.  Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

Authors:  E J Topol
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

8.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.

Authors:  D R Thiemann; J Coresh; S P Schulman; G Gerstenblith; W J Oetgen; N R Powe
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

9.  Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.

Authors:  F Van De Werf; J Adgey; D Ardissino; P W Armstrong; P Aylward; G Barbash; A Betriu; A S Binbrek; R Califf; R Diaz; R Fanebust; K Fox; C Granger; J Heikkilä; S Husted; P Jansky; A Langer; E Lupi; A Maseri; J Meyer; J Mlczoch; D Mocceti; D Myburgh; A Oto; E Paolasso; K Pehrsson; R Seabra-Gomes; L Soares-Piegas; D Sùgrue; M Tendera; E Topol; P Toutouzas; A Vahanian; F Verheugt; L Wallentin; H White
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

10.  Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.

Authors: 
Journal:  Lancet       Date:  2001-08-25       Impact factor: 79.321
View more
  5 in total

1.  Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.

Authors:  Anthony Kerigan
Journal:  CMAJ       Date:  2002-03-19       Impact factor: 8.262

Review 2.  Rising to the challenge: transforming the treatment of ST-segment elevation myocardial infarction.

Authors:  William A Ghali; Cameron R Donaldson; Merril L Knudtson; Steven J Lewis; Colleen J Maxwell; Jack V Tu
Journal:  CMAJ       Date:  2003-07-08       Impact factor: 8.262

Review 3.  Primary angioplasty for ST-segment elevation myocardial infarction: ready for prime time?

Authors:  Madhu K Natarajan; Salim Yusuf
Journal:  CMAJ       Date:  2003-07-08       Impact factor: 8.262

Review 4.  Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit.

Authors:  Paul W Armstrong; Robert C Welsh
Journal:  CMAJ       Date:  2003-10-28       Impact factor: 8.262

5.  Quality of care of patients with acute myocardial infarction in Bulgaria: a cross-sectional study.

Authors:  Milka Ganova-Iolovska; Krassimir Kalinov; Max Geraedts
Journal:  BMC Health Serv Res       Date:  2009-01-26       Impact factor: 2.655
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.